최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한방사선종양학회지 = The Journal of the Korean soceity for therapeutic radiology and oncology, v.24 no.2, 2006년, pp.128 - 137
장세경 (포천중문의과대학교 분당차병원 방사선종양학과) , 김성희 (연세대학교 의과대학 방사선종양학교실) , 신현수 (포천중문의과대학교 분당차병원 방사선종양학과) , 성진실 (연세대학교 의과대학 방사선종양학교실)
Purpose: We investigated whether a relationship exists between tumor control dose 50 (
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
West CM, Davidson SE, Hendry JH, Hunter RD. Prediction of cervical carcinoma response to radiotherapy. Lancet 1991;338:818
Hockel M, Knoop C, Schlenger K, et al. Intratumoral $pO_{2}$ predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50
Begg AC, Hofland I, Van Glabekke M, Bartelink H, Horiot JC. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851. Semin Radiat Oncol 1992;2: 22-25
Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515
Giaccia AJ, Brown JM, Wouters B, Denko N, Koumenis C. Cancer therapy and tumor physiology. Science 1998; 279:12-13
Stausbol-Gron B, Overgaard J. Relationship between tumour cell in vitro radiosensitivity and clinical outcome after curative radiotherapy for squamous cell carcinoma of the head and neck. Radiother Oncol 1999;50:47-55
Begg AC, Haustermans K, Hart AAM, et al. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis. Radiother Oncol 1999;50:13-23
Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 1991; 127:308-316
Meyn RE, Stephens LC, Ang KK, et al. Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 1993;64:583-591
Wheeler JA, Stephens LC, Tornos C, et al. ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage Ib cervical carcinoma. Int J Radiat Oncol Biol Phys 1995;32:1487-1493
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-6311
Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967
El-Deiry Ws, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75: 817-825
Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80:293-299
Reed JC. Double identity for proteins of the bcl-2 family. Nature 1997;387:773-776
Lee JM, Bernstein A. p53 mutations increase resistance to ionizing radiation. Proc Natl Acad Sci USA 1993;90:5742-5746
McIlwrath AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild type p53 for radiosensitivity. Cancer Res 1994;54:3718-3722
Kastan MB, Canman CE, Leonard CJ. p53, cell cycle control and apoptosis: implications for cancer. Cancer Metastasis Rev 1995;14:3-15
Smith ML, Fornace Jr AJ. The two faces of tumor suppressor p53. Am J Pathol 1996;148:1019-1022
Hawkins DS, Demers GW, Galloway DA. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents. Cancer Res 1996;56:892-898
Fan S, Smith ML, Rivert II DJ, et al. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res 1995;55:1649-1654
Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res 1993;53:3667-3669
Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D, Deisseroth AB. High levels of constitutive WAF1/ Cip1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res 1995;1:1051-1057
Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716
Fan S, Chang JK, Smith ML, Duba D, Fornace Jr AJ, O'Connor PM. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard. Oncogene 1997;14:2127-2136
Saito Y, Milross CG, Hittelman WN, et al. Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction. Int J Radiat Oncol Biol Phys 1997;38:623-631
Waldman T, Zhang Y, Dillehay L, et al. Cell-cycle arrest versus cell death in cancer therapy. Nature Med 1997;3: 1034-1036
Wouters BG, Giaccia AJ, Denko NC, Brown JM. Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis- independent mechanism. Cancer Res 1997;57:4703-4706
Ruan S, Okcu MF, Ren JP, et al. Overexpressed WAF1/ Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis (2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res 1998;58:1538-1543
Stephens LC, Hunter NR, Ang KK, Milas L, Meyn RE. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 1993;135:75-80
Milas L, Wike J, Hunter N, Volpe J, Basic I. Macrophage content of Murine sarcomas and carcinomas: associations with tumor growth parameters and tumor radiocurability. Cancer Res 1987;47:1069-1075
Milas L, Hunter NR, Mason KA, Milross CG, Saito Y, Peters LJ. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 1995; 55:3564-3568
Silchenmyer WJ, Nelson WG, Slebos RJ, Kastan MB. Loss of a p53 associated G1 checkpoint dose not decrease cell survival following DNA damage. Cancer Res 1993;53: 4164-4168
Pardo FS, Su M, Borek C, et al. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat Res 1994;140:180-185
Russell KJ, Wiens LW, Demers GW, Dalloway DA, Plon SE, Groudine M. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint deficient and G1 checkpoint competent cells. Cancer Res 1995;55:1639-1642
O'Connor PM, Jackman J, Jondle D, Bhatia K, Magrath I, Kohn KW. Role of the p53 tumor suppressor gene in cell cycle arrest and radiosensitivity of Burkitt's lymphoma cell lines. Cancer Res 1993;53:4776-4780
Maity A, Kao GD, Muschel RJ, McKenna WG. Potential molecular targets for manipulating the radiation response. Int J Radiat Oncol Biol Phys 1997;37:639-653
Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-1828
Jin P, Gu Y, Morgan DO. Role of inhibitory CDC2 phosphorylation in radiation induced G2 arrest in human cells. J Cell Biol 1996;134:963-970
Wu HG, Kim IH. Significance of apoptotic cell death after $\gamma$ - irradiation. J Korean Soc Ther Radiol Oncol 2001;19:252-258
Leoncini L, Vecchio MTD, Megha T, et al. Correlation between apoptotic and proliferative indices in malignant non- Hodgkin's lymphomas. Am J Pathol 1993;142:755-763
Lera J, Lara PC, Perez S, Cabrera JL, Santana C. Tumor proliferation, p53 expression, and apoptosis in laryngeal carcinoma. Cancer 1998;83:2493-2501
Akimoto T, Seong J, Hunter NR, Buchmiller L, Mason K, Milas L. Association of increased radiocurability of murine carcinomas with low constitutive expression of $p21^{WAF1/CIP1}$ protein. Int J Radiat Oncol Biol Phys 1999;44:413-419
Tamamoto T, Ohnishi K, Takahashi A, et al. Correlation between r-ray induced G2 arrest and radioresistance in two human cancer cells. Int J Radiat Oncol Biol Phys 1999;44: 905-909
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.